Hyderabad Life Sciences Ecosystem – India’s Boston for Biomedical Innovation
Hyderabad has emerged as one of the most influential life sciences hubs in Asia, bringing together pharmaceuticals, biotechnology, vaccines, genomics, research institutions, startups, and global capability centers into a single innovation ecosystem. Often compared to Boston for its concentration of scientific talent, research infrastructure, and industry collaboration, the city represents India’s most powerful convergence of science, healthcare, and entrepreneurship.
This session explores how Hyderabad is shaping the future of biomedical innovation and why it is increasingly becoming the preferred destination for research, drug discovery, manufacturing, translational medicine, and deep-tech healthcare startups. Discussions will examine the role of public policy, scientific institutions, industrial partnerships, and global investments in accelerating the region’s growth.
The session features distinguished leaders from government and scientific research. Mr. Sarvesh Singh, Director & CEO of Pharma & Life Sciences, Telangana, brings strategic insights into Telangana’s vision for becoming a global life sciences powerhouse through initiatives supporting biotechnology, pharmaceuticals, medical devices, and innovation-led economic growth.
Joining him is Dr. D. Srinivasa Reddy, Director of CSIR-Indian Institute of Chemical Technology (CSIR-IICT), one of India’s foremost scientific leaders in medicinal chemistry and drug discovery. A recipient of the prestigious Shanti Swarup Bhatnagar Prize, Dr. Reddy has played a significant role in advancing translational research and strengthening India’s scientific capabilities in pharmaceutical innovation. Under his leadership, CSIR-IICT continues to contribute to drug discovery, sustainable chemistry, and technology commercialization.
Together, the speakers will discuss how Hyderabad can accelerate its transition from a manufacturing powerhouse to a globally recognized innovation-driven biomedical ecosystem. Topics will include deep-tech research, startup incubation, public-private partnerships, global collaborations, talent development, and the future of healthcare innovation in India.
For healthcare leaders, investors, researchers, entrepreneurs, and policymakers, this session provides a strategic understanding of how scientific excellence, infrastructure, and innovation policy can create one of the world’s most dynamic life sciences ecosystems.
